Workflow
NKGen Biotech to Present Troculeucel Clinical and Biomarker Results at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
GlobeNewswire· 2025-05-07 12:00
SANTA ANA, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer ("NK") cell therapeutics, today announced an upcoming presentation on Phase 1 clinical data from the Company's Phase 1/2a trial evaluating troculeucel, cryopreserved expanded autologous NK cell therapy, in patients with moderate Alzheimer's disease (AD), at ...
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
GlobeNewswire· 2025-05-07 12:00
RADNOR, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced that management will be participating in the Bank of America Securities 2025 Health Care Conference being held in Las Vegas on May 12-15, 2025. Bank of America Securities Health Care Conferen ...
LGI Homes is Now Selling at Creekside Estates Near Dallas
GlobeNewswire· 2025-05-07 12:00
The Cypress Plan by LGI Homes at Creekside Estates features four bedrooms, two-and-a-half bathrooms, and an expansive living area. TERRELL, Texas, May 07, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) is excited to announce that sales have commenced in Creekside Estates in Terrell, Texas. LGI Homes is building 141 lots in this charming community in Kaufman County, offering homebuyers a perfect combination of small-town living, vibrant local attractions and easy access to Dallas. Creekside Estates ...
Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire· 2025-05-07 12:00
Recent Highlights and Anticipated Milestones: Bitopertin: GlyT1 Inhibitor (Heme Synthesis Modulator) DISC-0974: Anti-Hemojuvelin Antibody (Hepcidin Suppression) Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with EPP Plan to initiate Phase 2 study of DISC-3405 in polycythemia vera (PV) in H1 2025 Expect data readouts for DISC-0974 program in H2 2025, including init ...
22nd Century Group Further Reduces Debt by $1.0 Million Following Financing Transaction
GlobeNewswire· 2025-05-07 12:00
Year to Date Total Debt Reduction of approximately $3.8 Million MOCKSVILLE, N.C., May 07, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced that has repaid an additional $1 million in debt to its senior lender. The Company's total debt principal outstanding now stands at approximately $3.9 million. "Our debt reduction pro ...
Krystal Biotech to Present at BofA Securities 2025 Health Care Conference
GlobeNewswire· 2025-05-07 12:00
PITTSBURGH, May 07, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference on May 14, 2025, in Las Vegas. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 11:20 am PT and host investor meetings throughout the day. A webcast of the presentation will be available here beginning at 11:20 am PT on Wednesday, May 14, 2025 and will be po ...
Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology
GlobeNewswire· 2025-05-07 12:00
Daxor's ezBVA Lab Service Marks New Standard in Precision Fluid Management Oak Ridge, TN, May 07, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the opening of a new BVA program at a premier Florida healthcare center in the Tampa Bay region. This expansion integrates Daxor's innovative blood volume analysis (BVA) testing across the facility's inpatient and outpatient care programs, revolutionizing fluid management precision ...
Cycurion’s W. Eric Singleton to Speak at the Armed Forces Communication and Electronics Association’s TechNet Cyber 2025 on Active Cyber Defense Innovation
GlobeNewswire· 2025-05-07 12:00
MCLEAN, Va., May 07, 2025 (GLOBE NEWSWIRE) -- Cycurion (Nasdaq: CYCU) ("Cycurion" or the "Company"), a trusted leader in IT cybersecurity solutions and AI, announces that W. Eric Singleton, Vice President of Operations, will be a featured speaker at the Armed Forces Communications and Electronics Association's (AFCEA) TechNet Cyber 2025, one of the premier events for cyber leaders in the Department of Defense, intelligence community, and defense industry. Mr. Singleton's presentation is titled, "ARx: Active ...
Pyxis Tankers Announces Loan Commitment for Potential Fleet Expansion
GlobeNewswire· 2025-05-07 12:00
The Company currently owns a modern fleet of six mid-sized eco-vessels, which are engaged in the seaborne transportation of a broad range of refined petroleum products and dry-bulk commodities and consists of three MR product tankers, one Kamsarmax bulk carrier and controlling interests in two dry-bulk joint ventures of a sister-ship Kamsarmax and an Ultramax. The Company is positioned to opportunistically expand and maximize its fleet of eco-efficient vessels due to significant capital resources, competiti ...
Procedure for the Payment of AB Kauno Energija Dividends for 2024
GlobeNewswire· 2025-05-07 12:00
Residents of the foreign countries, which have concluded agreements on Avoidance of Double Taxation with the Republic of Lithuania, could take advantage of reduced tariffs provided by such agreements by submitting Claim for Reduction or Exemption from the Anticipatory Tax Withheld at Source, form FR0021 (DAS-1). The form should be completed following the law requirements and presented to AB Kauno Energija (email: info@kaunoenergija.lt) together with the broker's confirmation by 16 May 2025. For additional i ...